Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000668163 | SCV000792718 | uncertain significance | Enhanced S-cone syndrome; Retinitis pigmentosa 37 | 2017-07-20 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001323098 | SCV001514000 | uncertain significance | not provided | 2021-03-18 | criteria provided, single submitter | clinical testing | This sequence change replaces proline with serine at codon 152 of the NR2E3 protein (p.Pro152Ser). The proline residue is weakly conserved and there is a moderate physicochemical difference between proline and serine. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals with NR2E3-related conditions. ClinVar contains an entry for this variant (Variation ID: 552825). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Natera, |
RCV001835088 | SCV002085607 | uncertain significance | Enhanced S-cone syndrome | 2020-05-04 | no assertion criteria provided | clinical testing |